
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 193 pages)
“Benign tumors in myotonic dystrophy type I target disease-related cancer sites”, Ann Clin Transl Neurol, vol. 6, pp. 1510-1518, 2019.
, “Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity”, JNCI Cancer Spectr, vol. 2, p. pky052, 2018.
, “Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I”, Int J Cancer, 2019.
,